Cerebrolysin is a mixture of free amino acids and hundreds of short peptides, so its stability cannot be read from one sequence the way it can for a single peptide. Every common route applies somewhere in the mix: oxidation, deamidation, aspartate isomerisation, aggregation and loss to surfaces, plus microbial growth if a dissolved vial is contaminated. Cold, dark storage, a dry cake and sterile technique slow all of them.
Why a mixture behaves differently
For a single peptide, the stability page normally walks through the sequence residue by residue. Cerebrolysin has no one sequence. Mass spectrometry of one sample found 638 distinct peptides, mainly fragments of tubulin alpha and beta chains, actin and myelin basic protein (Gevaert et al., Drug Testing and Analysis, 2015), and the preparation is described as mostly free amino acids with peptides under 10 kDa (Hartbauer et al., Journal of Neural Transmission, 2001). What follows from that, against the usual degradation routes in peptide solutions (Manning et al., Pharmaceutical Research, 2010):
- Oxidation somewhere. Fragments of structural proteins will include methionine, cysteine, tryptophan, histidine and tyrosine, the residues most open to oxidation (Li et al., Biotechnology and Bioengineering, 1995), and free amino acids of the same kinds can oxidise too.
- Deamidation and isomerisation somewhere. Asparagine, glutamine and aspartate occur across hundreds of fragments, so some of the fast Asn-Gly and Asp-Gly pairs are bound to be present.
- No single pace-setter. Each change affects a small share of the mixture, so the preparation drifts gradually rather than failing at one bond.
- Little to aggregate, mostly. Short fragments and free amino acids rarely form large aggregates, but hydrophobic fragments of membrane and cytoskeletal proteins can stick to each other or to surfaces.
That reasoning comes from the composition data and general peptide chemistry. No stability study of Cerebrolysin itself has been published that we could find.
The solution as a growth medium
A solution of amino acids and short peptides is, chemically, a nutrient broth. For a single synthetic peptide, contamination mainly risks enzymes cutting the peptide; for Cerebrolysin it also risks microbes growing in it, which can cloud the vial and change its composition. This is why sterile technique and the benzyl alcohol in bacteriostatic water matter as much as temperature for a mixed vial, a point our storage page makes as well.
Lyophilised versus reconstituted
A sealed lyophilised vial holds a dry cake with almost no water, so hydrolysis, deamidation and microbial growth have very little to work with. No supplier data sheet we could open gives a shelf-life figure for the powder, so the general peptide approach applies: the sealed vial is kept dry, dark and cold, in the fridge for near-term work or the freezer for longer holds. Days at room temperature in transit do not harm a dry cake.
Under our handling guidance a vial mixed with bacteriostatic water lasts 8 to 12 weeks at 2 to 8 °C in the dark, with quality slowly fading from around week 6 to 8. That is the general row on how long peptides last after mixing, applied here because no Cerebrolysin-specific figure exists. The full table is on how long Cerebrolysin lasts.
Temperature
Peptide reactions roughly double to triple in rate for every 10 °C rise, a general rule rather than a Cerebrolysin measurement, and microbial growth in a contaminated vial speeds up sharply above fridge temperature. A mixed vial goes straight back into the main body of the fridge after each access.
Light
Unlike some single peptides, the mixture is all but certain to contain light-absorbing residues, because tubulin and actin, its main parent proteins, contain tryptophan and tyrosine. Their photo-oxidation products include yellow chromophores (Dyer et al., Photochemical and Photobiological Sciences, 2006). Light is therefore a real factor for Cerebrolysin, and the vial is kept boxed and dark both as powder and in solution.
Freeze-thaw
Sealed powder can be frozen, kept dry and brought to room temperature before opening. A mixed vial that will be opened again is not frozen. Ice formation concentrates peptides, amino acids and salts at the crystal boundaries, and repeated cycles promote aggregation (Manning et al., 2010). For a mixture there is a further reason: the least soluble components can come out of solution as the liquid freezes and may not all go back in on thawing. Laboratories that need frozen solution split it into single-use aliquots and thaw each once.
Adsorption to surfaces
Peptides and protein fragments can stick to glass and plastic, and in a mixture the more hydrophobic fragments are the ones most likely to be lost this way. At the milligram per mL concentrations used when reconstituting a 60 mg vial, the share lost is small. It matters more in very dilute working solutions, which laboratories prepare fresh in low-binding tubes. No measurement exists for Cerebrolysin itself; this is general peptide chemistry.
pH
Strong acid speeds hydrolysis and aspartate cleavage across the whole mixture. Cerebrolysin needs no acid to dissolve; see the Cerebrolysin solubility guide.
What visible changes mean
Mixed Cerebrolysin should be a clear solution with no visible particles. Because the powder itself can be white to yellow, a faint, even tint present from the moment of mixing is not on its own a sign of damage. What matters is change. Discard the solution if it shows:
- Cloudiness that does not clear within 10 to 15 minutes of mixing, or that appears later.
- Strands, flakes, particles or sediment.
- Gel or thickening.
- Darkening, or a colour that changes after mixing.
- A history of being frozen and thawed, or left out overnight.
The general causes of haze and gel are covered in why peptides gel or go cloudy. Bench steps that protect stability are on the Cerebrolysin handling page.
All products supplied by Vistara Labs are intended for laboratory research use only. They are not drugs, are not approved for human or veterinary use, and are not intended to diagnose, treat, cure or prevent any condition. Nothing on this page constitutes medical advice or guidance for use in humans.